950 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Purchased by Hopwood Financial Services Inc.

Hopwood Financial Services Inc. purchased a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 950 shares of the exchange traded fund’s stock, valued at approximately $86,000.

A number of other institutional investors also recently bought and sold shares of the stock. Summit X LLC bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $208,000. Independent Advisor Alliance bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $1,950,000. Dorsey & Whitney Trust CO LLC increased its stake in shares of SPDR S&P Biotech ETF by 27.3% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 2,800 shares of the exchange traded fund’s stock valued at $252,000 after purchasing an additional 600 shares in the last quarter. Intellectus Partners LLC increased its stake in shares of SPDR S&P Biotech ETF by 4.0% during the fourth quarter. Intellectus Partners LLC now owns 11,164 shares of the exchange traded fund’s stock valued at $1,005,000 after purchasing an additional 425 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its stake in shares of SPDR S&P Biotech ETF by 6.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 81,438 shares of the exchange traded fund’s stock valued at $7,334,000 after purchasing an additional 4,823 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $87.15 on Thursday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The company has a 50 day simple moving average of $90.28 and a two-hundred day simple moving average of $95.02. The company has a market capitalization of $5.75 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.